Best ABT Molecular Imaging

What Best ABT Molecular Imaging does

Best ABT Molecular Imaging manufactures and sells the B-100 Biomarker Generator, a self-contained PET biomarker production system for hospitals and oncology centers. The B-100 integrates a self-shielded 7.5 MeV mini-cyclotron, single-use card-based micro-chemistry, and embedded automated quality control (HPLC, pH, radiochemical and radionuclidic purity) into a single 300 sq ft unit that produces unit doses of PET tracers — principally 18F-FDG and others including NaF, FMISO, FLT, choline, DOPA, PSMA, 13N, and 68Ga — at the point of care. Compared to conventional cyclotrons, the system reduces footprint by 92.5%, weight by 52%, operating expense by 75%, and personnel requirements from 4 FTE to 1 FTE, while eliminating the need for a shielded bunker.

The company operates under the TeamBest Global group alongside Best Medical International and Best Cyclotron Systems, following the 2018 acquisition of ABT Molecular Imaging assets and the 2022 merger with Best Cyclotron Systems. Best ABT's go-to-market is exclusively indirect: it sells through a worldwide network of regional distributors (Med-Spectrum in Europe/Middle East, Global Medical Solutions in Latin America, Allmed Solutions in Pakistan/Middle East/Africa, Owen Kane Molecular Imaging and DTC IIBS in Russia) targeting hospitals, university medical centers, and oncology centers in markets where centralized radiopharmacy infrastructure is absent or unreliable. Customer wins to date include Sveta Marina University Hospital (Bulgaria), Aga Khan University Hospital (Pakistan), and the Center of Radiosurgery in St. Petersburg (Russia), with 25+ BG-75/B-100 systems cumulatively deployed globally. Revenue is generated primarily through one-time hardware sales of the capital system with ongoing service support via the distributor network; pricing is not publicly disclosed.

Name

Best ABT Molecular Imaging

Legal name

Best ABT, Inc.

Website

https://bestabt.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Best ABT Molecular Imaging manufactures the B-100 Biomarker Generator, a compact self-shielded cyclotron system that produces PET biomarkers on demand at hospitals and oncology centers in markets lacking centralized radiopharmacy infrastructure, selling exclusively through a worldwide distributor network.

Ownership category

akta.pro rank

Product category

Molecular Imaging Equipment

NAICS

Irradiation Apparatus Manufacturing (334517), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Radioisotope Production (Reactor/Cyclotron/Gamma) (HLAIAGAD)

akta.pro secondary industries

Diagnostic Radiopharmaceuticals (SPECT/PET Tracers) (HLAIAGAA), Nuclear Medicine & Molecular Imaging (SPECT/PET) (HLAHABAE), Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)

Keywords

• PET biomarker generation
• Compact cyclotron systems
• Molecular imaging equipment
• Nuclear medicine devices
• Radiopharmaceutical production

Headquarters

HQ city

Louisville

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. B-100 Biomarker Generator Sales: Sale of the B-100 Biomarker Generator system (compact cyclotron with micro-chemistry and quality control) to hospitals, oncology centers, and diagnostic imaging facilities for on-site PET biomarker production. The system produces unit doses of molecular imaging drugs (PET biomarkers) at the point of use.
2. Service and Support: The company maintains a worldwide network of sales and service distributors providing ongoing support for installed systems.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Best ABT Molecular Imaging designs, manufactures, and sells compact self-shielded cyclotrons — most notably the B-100 Biomarker Generator — paired with integrated micro-chemistry and automated quality control modules for on-site production of PET biomarkers. Its systems are built to enable hospitals, cancer centers, and nuclear medicine departments to manufacture radiotracers in-house without depending on regional cyclotron supply or external radiopharmacies.

Product overview

Best ABT Molecular Imaging offers a portfolio of compact, self-shielded cyclotron systems and biomarker generators for PET imaging. The core product is the B-100 Biomarker Generator (formerly the BG-75), an integrated system that combines a 7.5 MeV self-shielded mini-cyclotron, micro-chemistry module, and automated quality control into a compact 300 sq ft footprint, producing PET biomarkers on demand at the point of care. The company also sells additional cyclotron models including the BG-95 Sub-Compact Self-Shielded Cyclotron (capable of producing multiple radioisotopes such as 18F-FDG, 18F-PSMA, 68Ga, and others), the B-11 cyclotron for medical and research radioisotope production, the B6-15 MeV proton cyclotron for national labs, the Sub-Compact Model 200 self-shielded cyclotron, and the B15 cyclotron — all sold through the Best Cyclotron Systems (BCSI) family of products. The portfolio is designed to address the global lack of access to PET imaging by offering systems that are significantly smaller, easier to install, and less expensive to operate than conventional cyclotron systems.

Differentiator

Problem solved

Functional benefit

Brands

• B-100 Biomarker Generator: Compact biomarker generator that produces unit doses of molecular imaging drugs for PET at point of use. Formerly called BG-75.

Quantifiable outcome

• Reduces PET lab footprint from 4,000 sq ft to 300 sq ft (92.5% reduction)
• +6 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered core.

• Diagnostic and Treatment Center of the International Institute of Biological Systems (DTC IIBS)coreChannel Partner/ Reseller/ Distributor · 17 March 2016DTC IIBS is the leading provider of diagnostic services in the Russian Federation, with a network of 80 imaging centers located in more than 60 cities in Russia. DTC IIBS selected the ABT BG-75 as uniquely suited for the Russian market due to its compact size and capability for local FDG production.
• Med-SpectrumcoreChannel Partner/ Reseller/ DistributorStrategic partnership agreement for distribution of ABT's 'Dose on Demand' Biomarker Generator in pan-European and Middle East markets. Med-Spectrum is described as a company focused on the distribution of leading brand solutions in diagnostic imaging and oncology.
• Global Medical Solutions (GMS)coreChannel Partner/ Reseller/ DistributorNew partnership with Global Medical Solutions, an international company focused on offering a complete portfolio of Molecular Imaging solutions. GMS has developed a sales and support infrastructure in Latin America, with a strategic focus in Mexico and several key Latin America markets.
• Allmed SolutionscoreChannel Partner/ Reseller/ DistributorABT's distribution partner in Pakistan and the region. In concert with Allmed Solutions, the BG-75 System was installed at Aga Khan University Hospital in December 2015 and placed into clinical operation in January 2016, producing over 400 clinical 18F-FDG doses.
• Owen Kane Molecular Imaging Inc.coreChannel Partner/ Reseller/ DistributorU.S. representative for DTC IIBS in St. Petersburg, Russia. Facilitated the installation of ABT's compact 'Dose on Demand' Biomarker Generator at the Center of Radiosurgery, Stereotactic Radiotherapy and Oncology in St. Petersburg, Russia.
• Oncology Centre Cyprus (Limassol)coreChannel Partner/ Reseller/ DistributorABT partnered with a world-renowned oncology group to install the BG-75 Biomarker Generator System in Cyprus at a new state-of-the-art Oncology Centre in Limassol. The installation was announced March 17, 2016, and represents the first Molecular Imaging capability in Cyprus.

Scale indicators6 records

Recent moves8 records

Expansion highlights3 records

Direct peers

• Siemens Healthineers: Through its PETNET Solutions radiopharmacy network and Eclipse cyclotron systems, Siemens is one of the largest providers of PET tracers and cyclotron hardware globally. A direct competitor in cyclotron manufacturing and the broader PET production ecosystem, with substantially greater scale and an integrated tracer distribution network.
• IBA (Ion Beam Applications): Belgium-based global leader in cyclotron technology for medical radioisotope production, including the Cyclone KIUBE and other PET cyclotrons. Directly comparable to Best ABT as a manufacturer of cyclotron systems targeting hospital-based radiopharmaceutical production, with a much larger installed base and broader product portfolio.
• Sumitomo Heavy Industries: Japanese manufacturer of medical cyclotrons (HM-12, HM-20 series) used for PET isotope production in hospitals and radiopharmacies. Directly comparable technology and customer base; primarily serves the Japanese and Asian markets but competes globally in the same equipment category.
• Advanced Cyclotron Systems: Canadian manufacturer of cyclotrons (TR-19, TR-24) for medical radioisotope production, including PET tracers. Directly comparable in product category (cyclotron manufacturing for hospital/radiopharmacy use), with a similar mid-sized, specialized positioning relative to the larger OEMs.
• GE HealthCare: Major medical equipment OEM with a PETtrace cyclotron line for hospital-based radiopharmaceutical production. Directly competes in the same product category (medical cyclotrons for PET tracer manufacturing) but serves predominantly large academic medical centers in developed markets rather than the emerging-market niche Best ABT targets.

Broad incumbents

• Lantheus Holdings: Established radiopharmaceutical company with a portfolio of diagnostic and therapeutic agents including PyL (PSMA-PET) and other PET tracers. Competes in the same end market — PET imaging agents — but via a centralized pharmaceutical distribution model rather than decentralized generator hardware.
• PETNET Solutions (Siemens Healthineers): Operates a global network of radiopharmacies producing and distributing PET tracers to hospitals under Siemens Healthineers. Directly competes as the incumbent centralized production model against Best ABT's on-site point-of-care production philosophy.
• Cardinal Health Nuclear & PET: Operates one of the largest radiopharmacy networks in the United States, producing and distributing FDG and other PET tracers to hospitals. Represents the centralized radiopharmacy model that Best ABT's decentralized B-100 system is explicitly designed to disrupt.
• Curium: One of the largest nuclear medicine companies globally, manufacturing and distributing radiopharmaceuticals (including FDG) across a broad geographic footprint. Competes with Best ABT's output (PET tracers) via centralized manufacturing and distribution rather than decentralized on-site systems.

Emerging players

• Telix Pharmaceuticals: Commercial-stage radiopharmaceutical company focused on theranostics and diagnostic imaging agents, including PSMA-targeted PET tracers. An emerging player in the broader PET tracer space whose growth in novel tracers (e.g., Illuccix) creates parallel demand for compact on-site production capability that Best ABT's B-100 is designed to serve.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/ABTMolecularImaging
• LinkedInlinkedin.com/company/abt-molecular-imaging

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Best ABT Molecular Imaging